In the last 12 months, insiders at IMPACT BIOMEDICAL INC. ($IBO) filed 10 transactions with the SEC: 4 open-market purchases totaling $5,173 and 6 sales totaling $319,861. Net insider sentiment: net selling.
IMPACT BIOMEDICAL INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Chan Heng Fai Ambrose (Director) — 1 transaction totaling $174,020
- DSS, INC. (TenPercentOwner) — 2 transactions totaling $88,006
- Grady Jason (Director) — 1 transaction totaling $32,505
- Macko Todd D (Chief Financial Officer) — 2 transactions totaling $25,330
- Heuszel Frank D (Chief Executive Officer) — 4 transactions totaling $5,173
View all SEC Filings for IMPACT BIOMEDICAL INC. (IBO).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | Macko Todd D | Chief Financial Officer | S | Common Stock | 1600 | $0.60 | 198,122.0000 | 12,185,412 | 0.80% | 0.01% |
| March 27, 2026 | Macko Todd D | Chief Financial Officer | S | Common Stock | 43400 | $0.56 | 155,122.0000 | 12,185,412 | 21.86% | 0.36% |
| March 23, 2026 | Grady Jason | Director | S | Common Stock | 50000 | $0.65 | 250,182.0000 | 12,185,412 | 16.66% | 0.41% |
| May 22, 2025 | DSS, INC. | TenPercentOwner | S | Common Stock | 115600 | $0.55 | 590,424.0000 | 11,503,955 | 16.37% | 1.00% |
| May 27, 2025 | DSS, INC. | TenPercentOwner | S | Common Stock | 45400 | $0.54 | 545,024.0000 | 11,503,955 | 7.69% | 0.39% |
| April 3, 2025 | Chan Heng Fai Ambrose | Director | S | Common stock | 351555 | $0.50 | 0.0000 | 11,503,955 | 100.00% | 3.06% |
| Dec. 5, 2024 | Heuszel Frank D | Chief Executive Officer | P | Common Stock | 500 | $2.26 | 97,344.0000 | 10,000,000 | 0.52% | 0.01% |
| Nov. 26, 2024 | Heuszel Frank D | Chief Executive Officer | P | Common Stock | 550 | $2.63 | 95,844.0000 | 10,000,000 | 0.58% | 0.01% |
| Nov. 27, 2024 | Heuszel Frank D | Chief Executive Officer | P | Common Stock | 500 | $2.61 | 96,844.0000 | 10,000,000 | 0.52% | 0.01% |
| Nov. 26, 2024 | Heuszel Frank D | Chief Executive Officer | P | Common Stock | 500 | $2.59 | 96,344.0000 | 10,000,000 | 0.52% | 0.01% |